Most of the interactions which were documented with alprazolam are with medication that modulate CYP3A4 action. Compounds that are inhibitors or inducers of CYP3A will be anticipated to improve or decrease plasma alprazolam concentrations, respectively. Drug products which were studied in vivo, coup